Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

B

British Columbia Cancer Agency

Status

Unknown

Conditions

Rectal Bleeding

Treatments

Other: Hemospray

Study type

Interventional

Funder types

Other

Identifiers

NCT02233933
RadP

Details and patient eligibility

About

Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis

Full description

20 patients with Radiation Proctitis will be randomized to receive either Argon Plasma Coagulation therapy alone or therapy with APC followed by Hemospray administration ;the treatment in each arm is administered during a sigmoidoscopic examination

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

bleeding from radiation proctitis

Exclusion criteria

pregnancy bleeding diathesis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

20 participants in 2 patient groups

argon plasma coagulation
Active Comparator group
Description:
argon plasma coagulation of radiation proctitis
Treatment:
Other: Hemospray
argon plasma coagulator and hemospray
Experimental group
Description:
treatment of radiation proctitis with argon plasma coagulator followed by application of hemospray
Treatment:
Other: Hemospray

Trial contacts and locations

0

Loading...

Central trial contact

Alan A Weiss, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems